Beijing Huibaoyuan Pharmaceutical Technology Co., Ltd.

Beijing Huibaoyuan Pharmaceutical Technology is a specialized pharmaceutical R&D and technology service provider based in Beijing, China. The company focuses on the development of high-end generic drugs, improved new drugs (Class 2), and advanced drug delivery systems. Its core expertise lies in formulation science, particularly in solubility enhancement, controlled-release technologies, and the development of complex oral dosage forms. Huibaoyuan provides comprehensive services ranging from pharmaceutical chemistry and analysis to clinical trial management and regulatory registration, often operating as a CRO/CDMO for major Chinese pharmaceutical firms. The company's internal and collaborative portfolio includes a variety of small molecule therapies targeting metabolic, cardiovascular, and central nervous system disorders.